PDVAC Executive summary 2016: 3rd annual meeting

WHO Headquarters, Salle D, Geneva, Switzerland, 8-10 June 2016

Overview

Report from the World Health Organization’s Third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8-10th June 2016

WHO’s Product Development for Vaccines Advisory Committee (PDVAC) was convened for the third time in June 2016. Their remit was to revisit the pathogen areas where there has been significant progress since recommendations from the 2015 meeting, as well as to consider new advances in the development of vaccines against other pathogens. 

WHO Team
Immunization, Vaccines and Biologicals (IVB)
Editors
Product Development for Vaccines Advisory Committee (PDVAC)
Number of pages
3